NX

Quanex Building Products Corporation Reports First Quarter 2025 Results with Margin Expansion and Progress in Tyman Acquisition Integration

Quanex Building Products Corporation reports significant sales growth, margin expansion, and cost synergies from the Tyman acquisition, alongside debt repayment efforts.

Quiver AI Summary

Quanex Building Products Corporation announced its financial results for the three months ending January 31, 2025, revealing a significant increase in net sales to $400 million, largely driven by the Tyman acquisition, which contributed $175.7 million. Although the gross margin improved to 23.1% from 21.5% a year prior, the company reported a net loss of $14.9 million, compared to a net income of $6.2 million in the same quarter of 2024. The integration of Tyman is progressing well, with cost synergies expected to reach $30 million, and the company has repaid $65 million in debt since the acquisition. Despite facing a softer macroeconomic environment, Quanex remains optimistic about demand improvement in the upcoming spring and summer seasons. The company reaffirmed its guidance for 2025, anticipating net sales of approximately $1.84 billion to $1.86 billion and adjusted EBITDA between $270 million to $280 million.

Potential Positives

  • Reported a significant increase in net sales of 67.3% year-over-year, driven by the contribution from the Tyman acquisition.
  • Achieved gross margin expansion, rising to 23.1% from 21.5%, indicating improved profitability.
  • Successfully repaid approximately $65 million in debt since the Tyman acquisition, demonstrating strong financial management and commitment to reducing leverage.
  • Confident outlook for demand improvement as spring approaches, supporting future revenue growth expectations.

Potential Negatives

  • Despite a significant increase in net sales attributed to the Tyman acquisition, the company's net loss of $14.9 million stands out as a concerning trend compared to a net income of $6.2 million in the same period last year.
  • Operating income dropped to a loss of $6.98 million from a previous profit, indicating potential difficulties in managing costs despite revenue growth.
  • Free cash flow turned negative, with a cash outflow of $24.1 million, highlighting potential liquidity issues or inefficiencies in cash management.

FAQ

What were Quanex's net sales for Q1 2025?

Quanex reported net sales of $400.0 million for the three months ended January 31, 2025.

How has the Tyman acquisition impacted Quanex's results?

The Tyman acquisition contributed significantly, yielding $175.7 million in net sales and enhancing overall financial results.

What cost synergies has Quanex realized from the Tyman acquisition?

Quanex is progressing well towards capturing $30 million in targeted cost synergies from the Tyman integration.

How much debt has Quanex repaid since acquiring Tyman?

Since closing the Tyman acquisition on August 1, 2024, Quanex has repaid approximately $65 million in debt.

What is Quanex's guidance for net sales in fiscal 2025?

Quanex estimates net sales of approximately $1.84 billion to $1.86 billion for fiscal 2025 based on current trends.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.


$NX Insider Trading Activity

$NX insiders have traded $NX stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NX stock by insiders over the last 6 months:

  • GEORGE LAVERNE WILSON (President & CEO) has made 1 purchase buying 4,328 shares for an estimated $99,673 and 1 sale selling 6,300 shares for an estimated $185,140.
  • SCOTT M. ZUEHLKE (Senior VP, CFO & Treasurer) purchased 435 shares for an estimated $10,048

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NX Hedge Fund Activity

We have seen 92 institutional investors add shares of $NX stock to their portfolio, and 135 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release




Margin Expansion Realized on Consolidated Basis




Results Lifted by Contribution from Tyman Acquisition




Realization of Cost Synergies from Tyman Acquisition Progressing Well




$65 Million of Debt Repaid Since Closing Tyman Acquisition



HOUSTON, March 10, 2025 (GLOBE NEWSWIRE) --



Quanex Building Products Corporation



(NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2025.



The Company reported the following selected financial results:














































































































Three Months Ended January 31,


($ in millions, except per share data)



2025




2024


Net Sales


$400.0


$239.2

Gross Margin


$92.3


$51.4


Gross Margin %




23.1%




21.5


%


Net (Loss) Income


($14.9)


$6.2

Diluted EPS


($0.32)


$0.19






Adjusted Net Income


$9.0


$8.4

Adjusted Diluted EPS


$0.19


$0.25

Adjusted EBITDA


$38.5


$19.3


Adjusted EBITDA Margin %




9.6


%




8.1


%







Cash (Used For) Provided by Operating Activities


($12.5)


$3.9

Free Cash Flow


($24.1)


($5.7)


(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)



George Wilson, Chairman, President and Chief Executive Officer, stated, “The first quarter of 2025 was a very busy time for Quanex internally and I would like to thank all my Quanex teammates for their continuous efforts as we navigate through the process of integrating legacy Quanex with legacy Tyman. The integration gained speed and traction during the quarter, and we remain confident in our ability to deliver on the $30 million cost synergy target. Volume came in as expected during the first quarter, and we were pleased with the margin expansion and the overall impact of the cost synergies we have realized to date. On a consolidated basis, results for the first quarter were again lifted by the contribution from the Tyman acquisition and we achieved margin expansion. Our continued focus on cash flow and managing working capital enabled us to repay approximately $12 million in debt during the first quarter of 2025, or approximately $65 million since closing the acquisition on August 1, 2024.



“Looking ahead, despite the soft macro backdrop, we continue to expect an improvement in demand as we enter the spring selling season and through the summer. Longer-term we also expect to benefit from the unwinding of pent-up demand as consumer confidence improves. Our near-term priorities are staying focused on the Tyman integration, capturing the targeted synergies, and generating cash flow to pay down debt.”




First Quarter Results Summary



Quanex reported net sales of $400.0 million during the three months ended January 31, 2025, which represents an increase of 67.3% compared to $239.2 million for the same period of 2024. The increase reflects the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have declined by 6.2% for the first quarter of 2025, mostly due to lower volume. The Company reported a decrease in net sales of 9.2% for the first quarter of 2025 in its North American Fenestration segment. In its North American Cabinet Components segment, Quanex reported an increase of 1.6% in net sales for the first quarter of 2025. Excluding foreign exchange impact, net sales were essentially flat in its European Fenestration segment. In addition, Quanex reported net sales of $175.7 million related to contributions from the Tyman acquisition during the first quarter of 2025. (See Sales Analysis table for additional information)



The increase in adjusted earnings for the three months ended January 31, 2025 was mostly attributable to the contribution from the Tyman acquisition combined with the realization of costs synergies.




Balance Sheet & Liquidity Update



The Company borrowed $770 million ($500 Term Loan A and $270 on Senior Secured Revolving Credit Facility) to acquire Tyman on August 1, 2024 and has repaid $65 million of debt since closing. As of January 31, 2025, the Company had total debt of $764.3 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA improved slightly to 3.6x. As of January 31, 2025, the Company’s LTM Net Income was $11.9 million and LTM Adjusted EBITDA was $201.7 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)



The leverage ratio for Quanex’s quarterly debt covenant compliance (“Debt Covenant Leverage Ratio”) for its lenders was 2.2x as of January 31, 2025. The Debt Covenant Leverage Ratio calculation is defined in the Company’s Amendment No. 1 to its Second Amended and Restated Credit Agreement, which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered “finance” leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition and only cash from domestic subsidiaries. The Debt Covenant Leverage Ratio would be 2.1x if calculated using the cash and cash equivalents amount on the balance sheet as of January 31, 2024.



Quanex’s liquidity was $301.5 million as of January 31, 2025, consisting of $50.0 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.




Share Repurchases



Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 150,000 shares of common stock for approximately $3.7 million at an average price of $24.66 per share during the three months ended January 31, 2025. As of January 31, 2025, approximately $59.1 million remained under the existing share repurchase authorization.




Outlook



Mr. Wilson commented, “We issued official guidance for 2025 as part of our Investor Day held at the New York Stock Exchange on February 6, 2025. Based on our results year-to-date, combined with our operational execution, recent demand trends and conversations with our customers, we are reaffirming our guidance for fiscal 2025. On a consolidated basis for fiscal 2025, we continue to estimate that we will generate net sales of approximately $1.84 billion to $1.86 billion, which we expect will yield Adjusted EBITDA* of $270 million to $280 million.



“Our capital allocation priorities continue to be paying down debt, evaluating growth opportunities and opportunistically buying back our stock. In addition, the finance and accounting teams are logging long hours working hard in conjunction with our external auditors on re-segmenting the business, so we will report in the new operating segments as soon as practical.”



*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income.




Conference Call and Webcast Information



The Company has also scheduled a conference call for Tuesday, March 11, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at

http://www.quanex.com

in the Investors section under Presentations & Events.



Participants can pre-register for the conference call using the following link:



https://register.vevent.com/register/BIafe91a1501e44eaaadfb84ddc0982237



Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at

http://www.quanex.com

in the Investors section under Presentations & Events.




About Quanex



Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.




Non-GAAP Terminology Definitions and Disclaimers



Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.



Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.



Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.




Forward Looking Statements



Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the acquisition of Tyman, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.
























































































































































































































































CONDENSED CONSOLIDATED STATEMENTS OF INCOME



(In thousands, except per share data)


(Unaudited)









Three Months Ended January 31,





2025




2024







Net sales


$

400,044



$

239,155


Cost of sales



307,728




187,723


Selling, general and administrative



66,650




32,363


Restructuring charges



7,904




-


Depreciation and amortization



24,740




11,152


Operating income



(6,978

)



7,917


Interest expense



(14,186

)



(1,068

)

Other, net



1,229




1,042


(Loss) income before income taxes



(19,935

)



7,891


Income tax benefit (expense)



5,050




(1,642

)

Net (loss) income


$

(14,885

)


$

6,249







(Loss) earnings per common share, basic


$

(0.32

)


$

0.19


(Loss) earnings per common share, diluted


$

(0.32

)


$

0.19







Weighted average common shares outstanding:




Basic



47,015




32,825


Diluted



47,015




33,043







Cash dividends per share


$

0.08



$

0.08























































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




CONDENSED CONSOLIDATED BALANCE SHEETS



(In thousands)


(Unaudited)










January 31, 2025




October 31, 2024



ASSETS






Current assets:





Cash and cash equivalents


$

49,982



$

97,744


Restricted Cash



5,486




5,251


Accounts receivable, net



164,347




197,689


Inventories



280,580




275,550


Income taxes receivable



5,283




5,937


Prepaid and other current assets



41,943




29,097


Total current assets



547,621




611,268


Property, plant and equipment, net



391,118




402,466


Operating lease right-of-use assets



125,002




126,715


Deferred tax assets



3,709




3,845


Goodwill



569,688




574,711


Intangible assets, net



580,081




597,909


Other assets



3,270




2,874


Total assets


$

2,220,489



$

2,319,788








LIABILITIES AND STOCKHOLDERS' EQUITY






Current liabilities:





Accounts payable


$

108,374



$

124,404


Accrued liabilities



81,302




103,623


Income taxes payable



-




6,620


Current maturities of long-term debt



25,827




25,745


Current operating lease liabilities



13,275




12,475


Total current liabilities



228,778




272,867


Long-term debt



725,231




737,198


Noncurrent operating lease liabilities



115,517




117,560


Deferred income taxes



162,846




162,304


Other liabilities



16,001




19,113


Total liabilities



1,248,373




1,309,042


Stockholders’ equity:





Common stock



512




513


Additional paid-in-capital



697,358




701,008


Retained earnings



411,708




430,405


Accumulated other comprehensive loss



(62,379

)



(46,428

)

Treasury stock at cost



(75,083

)



(74,752

)

Total stockholders’ equity



972,116




1,010,746


Total liabilities and stockholders' equity


$

2,220,489



$

2,319,788

















































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW



(In thousands)


(Unaudited)





`


Three Months Ended January 31,




2025




2024



Operating activities:





Net (loss) income

$

(14,885

)


$

6,249


Adjustments to reconcile net income to cash provided by operating activities:




Depreciation and amortization


24,740




11,152


Stock-based compensation


902




583


Deferred income tax


2,851




1,136


Other, net


6,173




1,790


Changes in assets and liabilities:




Decrease in accounts receivable


30,330




18,147


Increase in inventory


(8,602

)



(8,756

)

Increase in other current assets


(8,985

)



(1,680

)

Decrease in accounts payable


(16,548

)



(19,044

)

Decrease in accrued liabilities


(22,558

)



(7,181

)

(Decrease) increase in income taxes receivable


(5,087

)



264


(Decrease) increase in other long-term liabilities


(247

)



852


Other, net


(594

)



342


Cash (used for) provided by operating activities


(12,510

)



3,854



Investing activities:





Business acquisition




Capital expenditures


(11,624

)



(9,580

)

Proceeds from disposition of capital assets


169




31


Cash used for investing activities


(11,455

)



(9,549

)


Financing activities:





Borrowings under credit facilities


45,000




-


Repayments of credit facility borrowings


(56,250

)



(5,000

)

Repayments of other long-term debt


(2,026

)



(679

)

Common stock dividends paid


(3,812

)



(2,645

)

Issuance of common stock


214




400


Payroll tax paid to settle shares forfeited upon vesting of stock


(1,400

)



(1,193

)

Purchase of treasury stock


(3,698

)



-


Cash used for financing activities


(21,972

)



(9,117

)

Effect of exchange rate changes on cash and cash equivalents


(1,590

)



760


Increase in cash, cash equivalents and restricted cash


(47,527

)



(14,052

)

Cash, cash equivalents and restricted cash at beginning of period


102,995




58,474


Cash, cash equivalents and restricted cash at end of period

$

55,468



$

44,422























































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




FREE CASH FLOW AND NET DEBT RECONCILIATION



(In thousands)


(Unaudited)







The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.











Three Months Ended January 31,






2025




2024


Cash (used for) provided by operating activities



($12,510

)


$3,854


Capital expenditures




(11,624

)



(9,580

)


Free Cash Flow





($


24,134



)




($


5,726



)














The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.











As of January 31,






2025




2024


Term loan facility



$487,500



$0


Revolving credit facility




217,500



$10,000


Finance lease obligations

(1)





59,306




55,211


Total debt

(2)





764,306




65,211


Less: Cash and cash equivalents




49,982




44,422



Net Debt





$


714,324





$


20,789









(1) Includes $55.1 million and $51.7 million in real estate lease liabilities considered finance leases under U.S. GAAP as of January 31, 2025 and 2024, respectively.

(2) Excludes outstanding letters of credit.








































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




NON-GAAP FINANCIAL MEASURE DISCLOSURE




LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION



(In thousands, except per share data)


(Unaudited)













Reconciliation of Last Twelve Months Adjusted EBITDA




Three Months Ended January 31, 2025




Three Months Ended October 31, 2024




Three Months Ended July 31, 2024




Three Months Ended April 30, 2024




Total





Reconciliation




Reconciliation




Reconciliation




Reconciliation




Reconciliation


Net (loss) income as reported


$

(14,885

)


$

(13,917

)


$

25,350



$

15,377



$

11,925


Income tax (benefit) expense



(5,050

)



(3,621

)



6,688




4,314




2,331


Other, net



(1,229

)



2,671




(9,474

)



(4

)



(8,036

)

Interest expense



14,186




17,697




878




950




33,711


Depreciation and amortization



24,740




27,329




10,953




10,894




73,916


EBITDA



17,762




30,159




34,395




31,531




113,847


Cost of sales

(1)




-




887




1,507




631




3,025


Selling, general and administrative

(1),(2),(3)




12,876




50,004




6,133




7,862




76,875


Restructuring charges

(4)




7,904




-




-




-




7,904


Adjusted EBITDA


$

38,542



$

81,050



$

42,035



$

40,024



$

201,651













(1) Expense (gain) related to plant closure.

(2) Transaction, advisory fees, and reorganization costs.

(3) Amortization of step-up for purchase price adjustments on inventory.

(4) Restructuring charges related to severance and disposal of software.
























































































































































































































































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




NON-GAAP FINANCIAL MEASURE DISCLOSURE



(In thousands, except per share data)


(Unaudited)












Reconciliation of Adjusted Net Income and Adjusted EPS




Three Months Ended January 31, 2025




Three Months Ended January 31, 2024






Net Income




Diluted EPS




Net Income




Diluted EPS



Net (loss) income as reported


$

(14,885

)


$

(0.32

)


$

6,249



$

0.19



Net (loss) income reconciling items from below



23,847



$

0.51




2,121



$

0.06



Adjusted net income and adjusted EPS


$

8,962



$

0.19



$

8,370



$

0.25














Reconciliation of Adjusted EBITDA




Three Months Ended January 31, 2025




Three Months Ended January 31, 2024






Reconciliation






Reconciliation





Net (loss) income as reported


$

(14,885

)




$

6,249





Income tax (benefit) expense



(5,050

)





1,642





Other, net



(1,229

)





(1,042

)




Interest expense



14,186






1,068





Depreciation and amortization



24,740






11,152





EBITDA



17,762






19,069





EBITDA reconciling items from below



20,780






205





Adjusted EBITDA


$

38,542





$

19,274
















Reconciling Items




Three Months Ended January 31, 2025




Three Months Ended January 31, 2024






Income Statement




Reconciling Items




Income Statement




Reconciling Items



Net sales


$

400,044



$

-



$

239,155



$

-



Cost of sales



307,728




-




187,723




-



Selling, general and administrative



66,650




(12,876

)


(1),(2)



32,363




(205

)


(2


)


Restructuring charges



7,904




(7,904

)


(3


)



-




-



EBITDA



17,762




20,780




19,069




205



Depreciation and amortization



24,740




(10,650

)


(4


)



11,152




(3,229

)


(4


)


Operating income



(6,978

)



31,430




7,917




3,434



Interest expense



(14,186

)



-




(1,068

)



-



Other, net



1,229




(172

)


(5


)



1,042




(755

)


(5


)


(Loss) Income before income taxes



(19,935

)



31,258




7,891




2,679



Income tax benefit (expense)



5,050




(7,411

)


(6


)



(1,642

)



(558

)


(6


)


Net (loss) income


$

(14,885

)


$

23,847



$

6,249



$

2,121













Diluted (loss) earnings per share


$

(0.32

)




$

0.19

























(1) Amortization of step-up for purchase price adjustments on inventory.

(2) Transaction, advisory fees, and reorganization costs.

(3) Restructuring charges related to severance and disposal of software.

(4) Amortization expense related to intangible assets.

(5) Pension settlement refund and foreign currency transaction losses (gains).

(6) Tax impact of net income reconciling items.





































































































































































































































































































































































































































































































































































































































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




SELECTED SEGMENT DATA



(In thousands)


(Unaudited)














This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.




NA Fenestration




EU Fenestration




NA Cabinet Components




Tyman




Unallocated Corp & Other




Total



Three months ended January 31, 2025














Net sales


$

134,333



$

48,471



$

43,810



$

175,676



$

(2,246

)


$

400,044


Cost of sales



106,567




30,638




39,415




132,796




(1,688

)



307,728


Gross Margin



27,766




17,833




4,395




42,880




(558

)



92,316



Gross Margin %





20.7


%






36.8


%






10.0


%






24.4


%








23.1


%



Selling, general and administrative

(1)




16,133




7,920




5,268




34,378




2,951




66,650


Restructuring charges



-




-




-




7,904




-




7,904


Depreciation and amortization



4,779




2,610




3,009




14,263




79




24,740


Operating income (loss)



6,854




7,303




(3,882

)



(13,665

)



(3,588

)



(6,978

)

Depreciation and amortization



4,779




2,610




3,009




14,263




79




24,740


EBITDA



11,633




9,913




(873

)



598




(3,509

)



17,762


Expense related to plant closure (Cost of sales)



-




-




-




-




-




-


Net gain related to plant closure (SG&A)



-




-




-




-




-




-


Amortization of step-up for purchase price adjustments on inventory



-




-




-




9,007




-




9,007


Transaction, advisory fees, and reorganization costs



-




-




-




1,469




2,400




3,869


Restructuring charges related to severance and disposal of software









7,904




-




7,904


Adjusted EBITDA


$

11,633



$

9,913



$

(873

)


$

18,978



$

(1,109

)


$

38,542



Adjusted EBITDA Margin %





8.7


%






20.5


%






-2.0%






10.8


%








9.6


%

















Three months ended January 31, 2024














Net sales


$

147,995



$

49,437



$

43,137



$

-



$

(1,414

)


$

239,155


Cost of sales



118,368




31,703




38,743




-




(1,091

)



187,723


Gross Margin



29,627




17,734




4,394




-




(323

)



51,432



Gross Margin %





20.0


%






35.9


%






10.2


%










21.5


%



Selling, general and administrative

(1)




15,910




7,745




5,126




-




3,582




32,363


Depreciation and amortization



5,475




2,558




3,065




-




54




11,152


Operating income (loss)



8,242




7,431




(3,797

)



-




(3,959

)



7,917


Depreciation and amortization



5,475




2,558




3,065




-




54




11,152


EBITDA



13,717




9,989




(732

)



-




(3,905

)



19,069


Transaction and advisory fees



-




-




-




-




205




205


Adjusted EBITDA


$

13,717



$

9,989



$

(732

)


$

-



$

(3,700

)


$

19,274



Adjusted EBITDA Margin %





9.3


%






20.2


%






-1.7%










8.1


%
















(1) Includes stock-based compensation expense of $1.2 million and $2.6 million as of January 31, 2025 and January 31, 2024, respectively.










































































































































































































































































































































QUANEX BUILDING PRODUCTS CORPORATION




SALES ANALYSIS



(In thousands)


(Unaudited)









Three Months Ended January 31,





2025




2024








NA Fenestration:






United States - fenestration

$

100,429



$

111,634



International - fenestration


5,859




6,144



United States - non-fenestration


23,205




25,791



International - non-fenestration


4,840




4,426




$

134,333



$

147,995



EU Fenestration:



(1)







International - fenestration

$

42,056



$

41,751



International - non-fenestration


6,415




7,686




$

48,471



$

49,437



NA Cabinet Components:






United States - fenestration

$

3,452



$

3,675



United States - non-fenestration


40,063




39,179



International - non-fenestration


295




283




$

43,810



$

43,137



Tyman:






United States - fenestration

$

105,591



$

-



International - fenestration


69,282




-



United States - non-fenestration


785




-



International - non-fenestration


18




-




$

175,676



$

-








Unallocated Corporate & Other:






Eliminations

$

(2,246

)


$

(1,414

)



$

(2,246

)


$

(1,414

)







Net Sales


$

400,044



$

239,155







(1) Reflects a decrease of $0.9 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2025.






This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.